RAPID AND SUSTAINED IMPROVEMENTS IN BOTH SKIN AND MUSCULOSKELETAL SYMPTOMS CORRELATES WITH IMPROVED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kavanaugh, A. F. [1 ]
Birt, J. [2 ]
Lin, C. -Y. [2 ]
Benichou, O. [3 ]
Hufford, M. [2 ]
Gottlieb, A. B. [4 ]
机构：
[1] Univ CA San Diego Hlth Syst, La Jolla, CA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Paris, France
[4] New York Med Coll, New York, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.2331
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0316
引用
收藏
页码：1022 / 1022
页数：1
相关论文
共 50 条
  • [21] USTEKINUMAB RESULTS: IN RAPID, SUSTAINED AND CLINICALLY MEANINGFUL IMPROVEMENTS IN PHYSICAL DISABILITY AND QUALITY OF LIFE IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS: FROM A RANDOMIZED AND PLACEBO-CONTROLLED PHASE II TRIAL
    Kavanaugh, A.
    Menter, A.
    Han, C.
    Mendelsohn, A.
    Schenkel, B.
    Gottlieb, A.
    VALUE IN HEALTH, 2009, 12 (07) : A524 - A524
  • [22] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM FUTURE 1 AND FUTURE 2
    Strand, V.
    FitzGerald, O.
    Coates, L. C.
    Walsh, J. A.
    Canete, J. D.
    Bhosekar, V.
    Pricop, L.
    Gandhi, K.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 688 - 688
  • [23] Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies
    Husni, M. Elaine
    Mease, Philip J.
    Merola, Joseph F.
    Tillett, William
    Goldammer, Nadine
    Ink, Barbara
    Coarse, Jason
    Lambert, Jeremy
    Taieb, Vanessa
    Gladman, Dafna D.
    RMD OPEN, 2024, 10 (03):
  • [24] Etanercept treatment leads to rapid and sustained improvements in the quality of life of patients with moderate to severe psoriasis
    Feldman, S
    Kimball, A
    Woolley, J
    Zitnik, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A55 - A55
  • [25] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 104 WEEKS RESULTS FROM A PHASE 3 TRIAL, FUTURE 2
    McInnes, I. B.
    Mease, P. J.
    Ritchlin, C.
    Rahman, P.
    Gottlieb, A.
    Kirkham, B.
    Kajekar, R.
    Delicha, E. M.
    Pricop, L.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 145 - 145
  • [26] THE IMPACT OF SKIN ITCHING ON HEALTH RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS OUTPATIENT CLINIC PATIENTS
    Haugeberg, G.
    Kavanaugh, A.
    Michelsen, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1685 - 1686
  • [27] Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era
    Haugeberg, Glenn
    Michelsen, Brigitte
    Kavanaugh, Arthur
    RMD OPEN, 2020, 6 (01):
  • [28] Ixekizumab provides sustained improvement in signs and symptoms in patients with active psoriatic arthritis: Results from a phase 3 trial
    Helliwell, P.
    Lespessailles, E.
    Shuler, C. L.
    Mallbris, L.
    Erickson, J.
    Burkhardt, N.
    Fleischmann, R.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 42 - 44
  • [29] The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies
    Kavanaugh, Arthur
    Gottlieb, Alice
    Morita, Akimichi
    Merola, Joseph F.
    Lin, Chen-Yen
    Birt, Julie
    Shuler, Catherine L.
    Hufford, Matthew M.
    Thaci, Diamant
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (09) : 1215 - 1219
  • [30] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 4-YEAR RESULTS FROM THE PHASE 3 FUTURE 2 STUDY
    McInnes, Iain B.
    Kirkham, Bruce
    Nash, Peter
    Rahman, Proton
    Gottlieb, Alice B.
    Ding, Kevin
    Pricop, Luminita
    RHEUMATOLOGY, 2019, 58
12345